Gardnerella vaginalis
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A Gram-variable coccobacillus that overgrows in bacterial vaginosis when protective lactobacilli decline.
Infections
Bacterial vaginosis; associated with preterm birth and pelvic infection.
Signs and symptoms
Thin grey-white discharge with a fishy odor; often no symptoms.
Antibiotic and antimicrobial resistance
Metronidazole resistance and biofilm contribute to recurrence.
Treatment considerations
Metronidazole (oral or vaginal) or clindamycin per CDC guidelines; detection alone, in women with a healthy microbiome, may not indicate disease.

Sources
- CDC. Bacterial vaginosis (STI Treatment Guidelines).
- CDC. Sexually Transmitted Infections Treatment Guidelines, 2021.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.